Market Research Report

Tolvaptan API Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-17006
  • CAT ID : 4
  • Pages : 154
  • Date : Jun 2023
 

The global Tolvaptan API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity≥99% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tolvaptan API include Extrovis AG, Aurore Life Sciences Private Ltd, Lupin Ltd, Olon Spa, Alkem Laboratories Ltd, Msn Laboratories Private Ltd, Apotex Pharmachem India Pvt Ltd, Hetero Drugs Ltd and Otsuka Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Tolvaptan API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tolvaptan API. This report contains market size and forecasts of Tolvaptan API in global, including the following market information:
Global Tolvaptan API Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Tolvaptan API Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Tolvaptan API companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tolvaptan API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tolvaptan API Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Tolvaptan API Market Segment Percentages, by Type, 2022 (%)
Purity≥99%
Purity<99%
Global Tolvaptan API Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Tolvaptan API Market Segment Percentages, by Application, 2022 (%)
Tablet
Others
Global Tolvaptan API Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Tolvaptan API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tolvaptan API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Tolvaptan API revenues share in global market, 2022 (%)
Key companies Tolvaptan API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Tolvaptan API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Extrovis AG
Aurore Life Sciences Private Ltd
Lupin Ltd
Olon Spa
Alkem Laboratories Ltd
Msn Laboratories Private Ltd
Apotex Pharmachem India Pvt Ltd
Hetero Drugs Ltd
Otsuka Pharmaceutical
Jiangsu Hengrui Pharmaceuticals Co Ltd
Zhejiang Huahai Pharmaceutical Co Ltd
Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical
Chengdu Baiyu Pharmaceutical
Sichuan Ren'an Pharmaceutical
Nanjing Chia Tai Tianqing Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tolvaptan API, market overview.
Chapter 2: Global Tolvaptan API market size in revenue and volume.
Chapter 3: Detailed analysis of Tolvaptan API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tolvaptan API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tolvaptan API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Tolvaptan API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tolvaptan API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tolvaptan API Overall Market Size
2.1 Global Tolvaptan API Market Size: 2022 VS 2029
2.2 Global Tolvaptan API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Tolvaptan API Sales: 2018-2029
3 Company Landscape
3.1 Top Tolvaptan API Players in Global Market
3.2 Top Global Tolvaptan API Companies Ranked by Revenue
3.3 Global Tolvaptan API Revenue by Companies
3.4 Global Tolvaptan API Sales by Companies
3.5 Global Tolvaptan API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Tolvaptan API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Tolvaptan API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tolvaptan API Players in Global Market
3.8.1 List of Global Tier 1 Tolvaptan API Companies
3.8.2 List of Global Tier 2 and Tier 3 Tolvaptan API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tolvaptan API Market Size Markets, 2022 & 2029
4.1.2 Purity≥99%
4.1.3 Purity<99%
4.2 By Type - Global Tolvaptan API Revenue & Forecasts
4.2.1 By Type - Global Tolvaptan API Revenue, 2018-2023
4.2.2 By Type - Global Tolvaptan API Revenue, 2024-2029
4.2.3 By Type - Global Tolvaptan API Revenue Market Share, 2018-2029
4.3 By Type - Global Tolvaptan API Sales & Forecasts
4.3.1 By Type - Global Tolvaptan API Sales, 2018-2023
4.3.2 By Type - Global Tolvaptan API Sales, 2024-2029
4.3.3 By Type - Global Tolvaptan API Sales Market Share, 2018-2029
4.4 By Type - Global Tolvaptan API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tolvaptan API Market Size, 2022 & 2029
5.1.2 Tablet
5.1.3 Others
5.2 By Application - Global Tolvaptan API Revenue & Forecasts
5.2.1 By Application - Global Tolvaptan API Revenue, 2018-2023
5.2.2 By Application - Global Tolvaptan API Revenue, 2024-2029
5.2.3 By Application - Global Tolvaptan API Revenue Market Share, 2018-2029
5.3 By Application - Global Tolvaptan API Sales & Forecasts
5.3.1 By Application - Global Tolvaptan API Sales, 2018-2023
5.3.2 By Application - Global Tolvaptan API Sales, 2024-2029
5.3.3 By Application - Global Tolvaptan API Sales Market Share, 2018-2029
5.4 By Application - Global Tolvaptan API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Tolvaptan API Market Size, 2022 & 2029
6.2 By Region - Global Tolvaptan API Revenue & Forecasts
6.2.1 By Region - Global Tolvaptan API Revenue, 2018-2023
6.2.2 By Region - Global Tolvaptan API Revenue, 2024-2029
6.2.3 By Region - Global Tolvaptan API Revenue Market Share, 2018-2029
6.3 By Region - Global Tolvaptan API Sales & Forecasts
6.3.1 By Region - Global Tolvaptan API Sales, 2018-2023
6.3.2 By Region - Global Tolvaptan API Sales, 2024-2029
6.3.3 By Region - Global Tolvaptan API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Tolvaptan API Revenue, 2018-2029
6.4.2 By Country - North America Tolvaptan API Sales, 2018-2029
6.4.3 US Tolvaptan API Market Size, 2018-2029
6.4.4 Canada Tolvaptan API Market Size, 2018-2029
6.4.5 Mexico Tolvaptan API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Tolvaptan API Revenue, 2018-2029
6.5.2 By Country - Europe Tolvaptan API Sales, 2018-2029
6.5.3 Germany Tolvaptan API Market Size, 2018-2029
6.5.4 France Tolvaptan API Market Size, 2018-2029
6.5.5 U.K. Tolvaptan API Market Size, 2018-2029
6.5.6 Italy Tolvaptan API Market Size, 2018-2029
6.5.7 Russia Tolvaptan API Market Size, 2018-2029
6.5.8 Nordic Countries Tolvaptan API Market Size, 2018-2029
6.5.9 Benelux Tolvaptan API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Tolvaptan API Revenue, 2018-2029
6.6.2 By Region - Asia Tolvaptan API Sales, 2018-2029
6.6.3 China Tolvaptan API Market Size, 2018-2029
6.6.4 Japan Tolvaptan API Market Size, 2018-2029
6.6.5 South Korea Tolvaptan API Market Size, 2018-2029
6.6.6 Southeast Asia Tolvaptan API Market Size, 2018-2029
6.6.7 India Tolvaptan API Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Tolvaptan API Revenue, 2018-2029
6.7.2 By Country - South America Tolvaptan API Sales, 2018-2029
6.7.3 Brazil Tolvaptan API Market Size, 2018-2029
6.7.4 Argentina Tolvaptan API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tolvaptan API Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Tolvaptan API Sales, 2018-2029
6.8.3 Turkey Tolvaptan API Market Size, 2018-2029
6.8.4 Israel Tolvaptan API Market Size, 2018-2029
6.8.5 Saudi Arabia Tolvaptan API Market Size, 2018-2029
6.8.6 UAE Tolvaptan API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Extrovis AG
7.1.1 Extrovis AG Company Summary
7.1.2 Extrovis AG Business Overview
7.1.3 Extrovis AG Tolvaptan API Major Product Offerings
7.1.4 Extrovis AG Tolvaptan API Sales and Revenue in Global (2018-2023)
7.1.5 Extrovis AG Key News & Latest Developments
7.2 Aurore Life Sciences Private Ltd
7.2.1 Aurore Life Sciences Private Ltd Company Summary
7.2.2 Aurore Life Sciences Private Ltd Business Overview
7.2.3 Aurore Life Sciences Private Ltd Tolvaptan API Major Product Offerings
7.2.4 Aurore Life Sciences Private Ltd Tolvaptan API Sales and Revenue in Global (2018-2023)
7.2.5 Aurore Life Sciences Private Ltd Key News & Latest Developments
7.3 Lupin Ltd
7.3.1 Lupin Ltd Company Summary
7.3.2 Lupin Ltd Business Overview
7.3.3 Lupin Ltd Tolvaptan API Major Product Offerings
7.3.4 Lupin Ltd Tolvaptan API Sales and Revenue in Global (2018-2023)
7.3.5 Lupin Ltd Key News & Latest Developments
7.4 Olon Spa
7.4.1 Olon Spa Company Summary
7.4.2 Olon Spa Business Overview
7.4.3 Olon Spa Tolvaptan API Major Product Offerings
7.4.4 Olon Spa Tolvaptan API Sales and Revenue in Global (2018-2023)
7.4.5 Olon Spa Key News & Latest Developments
7.5 Alkem Laboratories Ltd
7.5.1 Alkem Laboratories Ltd Company Summary
7.5.2 Alkem Laboratories Ltd Business Overview
7.5.3 Alkem Laboratories Ltd Tolvaptan API Major Product Offerings
7.5.4 Alkem Laboratories Ltd Tolvaptan API Sales and Revenue in Global (2018-2023)
7.5.5 Alkem Laboratories Ltd Key News & Latest Developments
7.6 Msn Laboratories Private Ltd
7.6.1 Msn Laboratories Private Ltd Company Summary
7.6.2 Msn Laboratories Private Ltd Business Overview
7.6.3 Msn Laboratories Private Ltd Tolvaptan API Major Product Offerings
7.6.4 Msn Laboratories Private Ltd Tolvaptan API Sales and Revenue in Global (2018-2023)
7.6.5 Msn Laboratories Private Ltd Key News & Latest Developments
7.7 Apotex Pharmachem India Pvt Ltd
7.7.1 Apotex Pharmachem India Pvt Ltd Company Summary
7.7.2 Apotex Pharmachem India Pvt Ltd Business Overview
7.7.3 Apotex Pharmachem India Pvt Ltd Tolvaptan API Major Product Offerings
7.7.4 Apotex Pharmachem India Pvt Ltd Tolvaptan API Sales and Revenue in Global (2018-2023)
7.7.5 Apotex Pharmachem India Pvt Ltd Key News & Latest Developments
7.8 Hetero Drugs Ltd
7.8.1 Hetero Drugs Ltd Company Summary
7.8.2 Hetero Drugs Ltd Business Overview
7.8.3 Hetero Drugs Ltd Tolvaptan API Major Product Offerings
7.8.4 Hetero Drugs Ltd Tolvaptan API Sales and Revenue in Global (2018-2023)
7.8.5 Hetero Drugs Ltd Key News & Latest Developments
7.9 Otsuka Pharmaceutical
7.9.1 Otsuka Pharmaceutical Company Summary
7.9.2 Otsuka Pharmaceutical Business Overview
7.9.3 Otsuka Pharmaceutical Tolvaptan API Major Product Offerings
7.9.4 Otsuka Pharmaceutical Tolvaptan API Sales and Revenue in Global (2018-2023)
7.9.5 Otsuka Pharmaceutical Key News & Latest Developments
7.10 Jiangsu Hengrui Pharmaceuticals Co Ltd
7.10.1 Jiangsu Hengrui Pharmaceuticals Co Ltd Company Summary
7.10.2 Jiangsu Hengrui Pharmaceuticals Co Ltd Business Overview
7.10.3 Jiangsu Hengrui Pharmaceuticals Co Ltd Tolvaptan API Major Product Offerings
7.10.4 Jiangsu Hengrui Pharmaceuticals Co Ltd Tolvaptan API Sales and Revenue in Global (2018-2023)
7.10.5 Jiangsu Hengrui Pharmaceuticals Co Ltd Key News & Latest Developments
7.11 Zhejiang Huahai Pharmaceutical Co Ltd
7.11.1 Zhejiang Huahai Pharmaceutical Co Ltd Company Summary
7.11.2 Zhejiang Huahai Pharmaceutical Co Ltd Tolvaptan API Business Overview
7.11.3 Zhejiang Huahai Pharmaceutical Co Ltd Tolvaptan API Major Product Offerings
7.11.4 Zhejiang Huahai Pharmaceutical Co Ltd Tolvaptan API Sales and Revenue in Global (2018-2023)
7.11.5 Zhejiang Huahai Pharmaceutical Co Ltd Key News & Latest Developments
7.12 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical
7.12.1 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Company Summary
7.12.2 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Tolvaptan API Business Overview
7.12.3 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Tolvaptan API Major Product Offerings
7.12.4 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Tolvaptan API Sales and Revenue in Global (2018-2023)
7.12.5 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Key News & Latest Developments
7.13 Chengdu Baiyu Pharmaceutical
7.13.1 Chengdu Baiyu Pharmaceutical Company Summary
7.13.2 Chengdu Baiyu Pharmaceutical Tolvaptan API Business Overview
7.13.3 Chengdu Baiyu Pharmaceutical Tolvaptan API Major Product Offerings
7.13.4 Chengdu Baiyu Pharmaceutical Tolvaptan API Sales and Revenue in Global (2018-2023)
7.13.5 Chengdu Baiyu Pharmaceutical Key News & Latest Developments
7.14 Sichuan Ren'an Pharmaceutical
7.14.1 Sichuan Ren'an Pharmaceutical Company Summary
7.14.2 Sichuan Ren'an Pharmaceutical Business Overview
7.14.3 Sichuan Ren'an Pharmaceutical Tolvaptan API Major Product Offerings
7.14.4 Sichuan Ren'an Pharmaceutical Tolvaptan API Sales and Revenue in Global (2018-2023)
7.14.5 Sichuan Ren'an Pharmaceutical Key News & Latest Developments
7.15 Nanjing Chia Tai Tianqing Pharmaceutical
7.15.1 Nanjing Chia Tai Tianqing Pharmaceutical Company Summary
7.15.2 Nanjing Chia Tai Tianqing Pharmaceutical Business Overview
7.15.3 Nanjing Chia Tai Tianqing Pharmaceutical Tolvaptan API Major Product Offerings
7.15.4 Nanjing Chia Tai Tianqing Pharmaceutical Tolvaptan API Sales and Revenue in Global (2018-2023)
7.15.5 Nanjing Chia Tai Tianqing Pharmaceutical Key News & Latest Developments
8 Global Tolvaptan API Production Capacity, Analysis
8.1 Global Tolvaptan API Production Capacity, 2018-2029
8.2 Tolvaptan API Production Capacity of Key Manufacturers in Global Market
8.3 Global Tolvaptan API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tolvaptan API Supply Chain Analysis
10.1 Tolvaptan API Industry Value Chain
10.2 Tolvaptan API Upstream Market
10.3 Tolvaptan API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tolvaptan API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250

Corporate User : $4225

Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe